Skip to main content
. 2024 Jan 12;14(1):e073866. doi: 10.1136/bmjopen-2023-073866

Table 3.

Clinical characteristics of primary care COVID-19 cases in CPRD Aurum, by high-risk definitions

All (n=2 257 907) Meeting NHS highest risk conditions (n=249 972) Meeting PANORAMIC criteria (n=6 91 593) Meeting UKHSA clinical risk (n=225 051)
Primary care cases meeting definition -- 11% 31% 10%
Smoking status
 Current smoker 298 735 (13%) 44 365 (17%) 121 019 (18%) 46 436 (21%)
 Former smoker 285 722 (13%) 67 637 (26%) 168 343 (24%) 63 124 (28%)
 Never smoked 580 239 (26%) 87 217 (34%) 228 579 (33%) 77 157 (34%)
 Unknown 1 093 211 (48%) 60 753 (23%) 173 652 (25%) 38 334 (17%)
Body mass index (kg/m2)
 Mean (SD) 27.6 (7.1) 29.1 (6.9) 29.5 (6.7) 29.5 (7.5)
 Underweight (< 18.5) 45 194 (2%) 3720 (1%) 5305 (1%) 5926 (3%)
 Not overweight (18.5–24.9) 226 272 (10%) 35 766 (14%) 81 363 (12%) 36 716 (16%)
 Overweight (25.0–29.9) 204 360 (9%) 45 261 (17%) 113 863 (16%) 43 758 (19%)
 Obese (≥30.0) 219 253 (10%) 53 814 (21%) 138 035 (20%) 62 494 (28%)
 Unknown 1 562 828 (69%) 121 411 (47%) 353 027 (51%) 76 157 (34%)
Charlson comorbidity index
 Mean (SD) 0.2 (0.6) 0.7 (1.3) 0.5 (1.0) 1.0 (1.3)
0 2 003 257 (89%) 165 823 (64%) 487 550 (71%) 102 790 (46%)
1 or 2 221 370 (10%) 74 805 (29%) 174 287 (25%) 99 830 (44%)
3 or 4 24 554 (1%) 12 659 (5%) 21 574 (3%) 15 961 (7%)
5+ 8726 (<1%) 6685 (3%) 8182 (1%) 6470 (3%)

CPRD, Clinical Practice Research Datalink; NHS, National Health Service; PANORAMIC, Platform Adaptive trial of NOvel antiviRals for eArly treatMent of COVID-19 In the Community; UKHSA, UK Health Security Agency.